Mid Penn Bancorp (NASDAQ:MPB) reported quarterly earnings of $0.97 per share. This is a 12.79 percent increase over earnings of $0.86 per share from the same period last year.
Recap Of Thursday’s Biotech Catalysts – End Of the Day Summary
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation for Intellia Therapeutics’ (NASDAQ:NTLA) lead asset NTLA-2002,…
